OverviewSuggest Edit

ConforMIS is a privately held medical device company developing personalized, patient-specific implants and instrumentation for knee-related therapeutics. The Company transforms traditional CT and MRI data into patient-specific implants and instrumentation employing two related image-to-implant technology platforms. Both platforms are supported by proprietary, intellectual property consisting and pending patent applications that span imaging software, image processing, implant design, surgical techniques and orthopedic instrumentation. The technology and patent portfolio is applicable to all major joint systems. To date, ConforMIS has developed a comprehensive line of minimally traumatic implant solutions to address all stages of knee osteoarthritis, the most common reason for knee replacement surgery.

HQBedford, US
Employee Ratings2.7

Latest Updates

Employees (est.) (Feb 2019)348
Job Openings40
Revenue (FY, 2018)$89.8 M(+15%)
Share Price (Mar 2019)$1.9 (+6%)

Key People/Management at ConforMIS

Amita Shah

Amita Shah

Vice President, Regulatory and Quality Affairs
John Slamin

John Slamin

Senior Vice President, Knee Implant Engineering
David Cerveny

David Cerveny

Senior Vice President, Intellectual Property & General Counsel
Adam Hayden

Adam Hayden

Vice President, Marketing
Show more

ConforMIS Office Locations

ConforMIS has an office in Bedford
Bedford, US (HQ)
28 Crosby Dr
Show all (1)
Report incorrect company information

ConforMIS Financials and Metrics

ConforMIS Revenue

Embed Graph
View revenue for all periods
ConforMIS's revenue was reported to be $89.79 m in FY, 2018

Revenue (FY, 2018)


Gross profit (FY, 2018)


Gross profit margin (FY, 2018), %


Net income (FY, 2018)


EBIT (FY, 2018)


Market capitalization (18-Mar-2019)


Closing stock price (18-Mar-2019)


Cash (31-Dec-2018)

ConforMIS's current market capitalization is $127 m.
USDFY, 2015FY, 2016FY, 2017FY, 2018



Revenue growth, %


Cost of goods sold


Gross profit

USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018



Cost of goods sold


Gross profit


Gross profit Margin, %

USDFY, 2015FY, 2016FY, 2017FY, 2018



Accounts Receivable




Current Assets

USDFY, 2015FY, 2016FY, 2017FY, 2018

Net Income


Depreciation and Amortization




Accounts Payable

USDY, 2018



Financial Leverage

1.7 x
Show all financial metrics
Report incorrect company information

ConforMIS Online and Social Media Presence

Embed Graph
Report incorrect company information

ConforMIS News and Updates

The 3D designed Conformis Hip System Announced at the 2019 AAOS conference

Designed to enhance operational efficiency for the surgeon and improve patient outcomes, the Conformis Hip System is the most advanced, patient conforming hip replacement system available Designed to enhance operational efficiency for the surgeon and improve patient outcomes, the Conformis Hip Syste…

Conformis Reports Fourth Quarter and Year Ended 2018 Financial Results

BILLERICA, Mass., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique ana…

Joint Replacement Devices Market Insights With Key Players Aesculap Implant Systems, Arthrex, Inc., ConforMIS, DePuy Synthes, Medtronic, Smith & Nephew

Joints are affected by a variety of conditions, including osteoporosis, degenerative bone disease, arthritis and gout. Posted via Industry Today. Follow us on Twitter @IndustryToday

A Comprehensive Study exploring Artificial Knee Joint Market | key players: Becton Dickinson, Arthrex, ConforMIS

Stay up-to-date with Artificial Knee Joint Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. Posted via Industry Today. Follow us on Twitter @IndustryToday

Unicompartmental Knee Prostheses Industry | Market Growth,Analysis by Application Forecast to 2025

Unicompartmental Knee Prostheses Industry report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. Unicompartmental knee arthroplasty is one of the essential treatment opportunities for tibiofemoral osteoarthritis. Posted via Industry To…

Knee Replacement Market 2018 – Higher ROI of the Medical Devices Sector will Trigger Investment

In the coming years, it is expected that the Global Knee Replacement Market will advance with higher growth rate as compared to previous years. Rising pressure to curb healthcare costs has fuelled the growth of the market for Knee Replacement market. Posted via Industry Today. Follow us on Twitter …
Report incorrect company information

ConforMIS Frequently Asked Questions

  • When was ConforMIS founded?

    ConforMIS was founded in 2004.

  • Who are ConforMIS key executives?

    ConforMIS's key executives are Amita Shah, John Slamin and David Cerveny.

  • How many employees does ConforMIS have?

    ConforMIS has 348 employees.

  • What is ConforMIS revenue?

    Latest ConforMIS annual revenue is $89.8 m.

  • What is ConforMIS revenue per employee?

    Latest ConforMIS revenue per employee is $258 k.

  • Who are ConforMIS competitors?

    Competitors of ConforMIS include Park-Ohio Holdings, STAAR Surgical and Glaukos.

  • Where is ConforMIS headquarters?

    ConforMIS headquarters is located at 28 Crosby Dr, Bedford.

  • Where are ConforMIS offices?

    ConforMIS has an office in Bedford.

  • How many offices does ConforMIS have?

    ConforMIS has 1 office.